STOCK TITAN

Biomarin Pharmaceutical Inc reported $3.2B in revenue and $348.9M in net income for fiscal 2025. See the full BMRN financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

BioMarin to Participate in Upcoming Investor Conferences

BioMarin (BMRN) will present at several healthcare investor conferences in September 2026, including events hosted by Wells Fargo, Cantor, Citi and Morgan Stanley.

(Neutral)
(Neutral)
Tags
conferences

BioMarin (BMRN) will present at several healthcare investor conferences in September 2026, including events hosted by Wells Fargo, Cantor, Citi and Morgan Stanley. Presentations take place between September 9 and 14, 2026, at specified times in Eastern Time.

Live audio webcasts and limited-time archives of BioMarin’s remarks will be accessible through the company’s investor relations website at https://investors.biomarin.com/. The company describes itself as a global rare disease biotechnology firm with nine commercial therapies and an active clinical and preclinical pipeline.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
  • Wells Fargo 21st Annual Healthcare Conference, September 9 at 3:00 pm EST
  • Cantor Global Healthcare Conference 2026, September 10 at 10:20 am EST
  • Citi's 2026 Biopharma Back to School Conference, September 10 at 1:00 pm EST
  • Morgan Stanley 24th Annual Global Healthcare Conference, September 14 at 10:00 am EST

SAN RAFAEL, Calif., Sept. 2, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at upcoming investor conferences in September.

BioMarin Pharmaceutical logo

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients.

To learn more, please visit www.biomarin.com.

Contacts:


Investors

Media

Traci McCarty

Marni Kottle

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(650) 374-2803

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-investor-conferences-302866797.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What upcoming investor conferences will BioMarin (BMRN) participate in September 2026?

BioMarin will participate in the Wells Fargo 21st Annual Healthcare Conference, Cantor Global Healthcare Conference 2026, Citi's 2026 Biopharma Back to School Conference and the Morgan Stanley 24th Annual Global Healthcare Conference, with presentations scheduled between September 9 and 14, 2026.

When is BioMarin (BMRN) presenting at the Wells Fargo 21st Annual Healthcare Conference?

BioMarin is scheduled to present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 3:00 p.m. EST.

What is the BioMarin (BMRN) presentation time at the Cantor Global Healthcare Conference 2026?

BioMarin’s presentation at the Cantor Global Healthcare Conference 2026 is scheduled for September 10, 2026, at 10:20 a.m. EST.

When will BioMarin (BMRN) present at Citi's 2026 Biopharma Back to School Conference?

BioMarin will present at Citi's 2026 Biopharma Back to School Conference on September 10, 2026, at 1:00 p.m. EST.

What is the BioMarin (BMRN) schedule for the Morgan Stanley 24th Annual Global Healthcare Conference?

BioMarin is scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, at 10:00 a.m. EST.

How can investors access the BioMarin (BMRN) webcasts for the September 2026 conferences?

Live audio webcasts of BioMarin’s September 2026 conference presentations will be available at https://investors.biomarin.com/. An archived version of the remarks will also be accessible on the company’s website for a limited time after each conference.

Will replays of BioMarin (BMRN) investor conference presentations be available?

Yes. An archived version of BioMarin’s conference remarks will be available through the company’s website for a limited time following each presentation, in addition to the live audio webcast.